AstraZeneca Launches Partner Recruitment for Healthcare Innovation Ecosystem Expansion in Saudi Arabia and Latin America

Dec 08, 2023 07:59 CST Updated 08:00

AstraZeneca

Biopharmaceutical Manufacturer

AstraZeneca PLC supports the creation of

Healthy Innovation Ecosystem,

Gathering forces from all sectors, including government, industry, academia, research, healthcare, and investment,

By continuously recruiting innovative partners,

Promote resource sharing and collaborative development,

Cultivate new technologies, new business forms, and new models,

To promote the high-quality development of China's healthcare industry,

And is committed to promoting the international development of China's medical innovation.

In July and September this year, a delegation of Chinese enterprises traveled to Brazil and Saudi Arabia respectively for cross-border health innovation ecosystem exchange and cooperation activities. These efforts helped nearly 30 Chinese enterprises deeply explore medical and health policies, market demands, and cooperation opportunities in the Middle East and Latin America. The accompanying Chinese enterprises covered industries such as pharmaceuticals, biotechnology, vaccines, medical devices, diagnostics, medical big data, and capital. During the visit, the delegation conducted in-depth exchanges with local government departments, industry associations, enterprise representatives, and investment institutions. They reached multiple cooperation agreements in areas such as local innovation introduction, product promotion, and ecosystem co-construction, boosting the "going global" of China's medical innovations.

In the first quarter of 2024, AstraZeneca Saudi and AstraZeneca Brazil will lead delegations to China for return visits. During this time, they will engage in forward-looking and authoritative exchange dialogues with leading companies in the industry and partners in the healthcare innovation ecosystem, focusing on China's national health industry policies and global healthcare innovation development trends!

Saudi Arabia Overseas Innovation Project Recruitment

1. Recruitment Needs：

Potential partners in the following fields with intentions to expand to Saudi Arabia

Demand 1: Enterprises related to mRNA vaccines

Demand Two: Enterprises Related to Cell and Stem Cell Therapy

Requirement Three: Companies providing clinical trials (especially Phase 1 and Phase 2) and real-world evidence studies related to oncology and infectious diseases.

Requirement Four: AI-related enterprises applied in the clinical trial stage

Requirement Five: AI-related enterprises in medical data applied to the clinical research stage

2. Requirement Deadline：

December 31, 2023

3. Project Cooperation Direction：

Outstanding projects will have the opportunity to join AstraZeneca's Saudi ecosystem, participate in the Saudi delegation's visit to China in early 2024, engage in in-depth exchanges with the Saudi delegation, gain potential investment cooperation opportunities, and discuss future collaboration directions.

Swipe up and down to view more

Latin America Overseas Innovation Project Recruitment

1. Recruitment Needs:

Partners in the following fields with intentions to expand to Brazil, Argentina, Mexico, and Colombia

Demand 1: Screening and diagnosis for chronic kidney disease, tumors (lung, breast), heart disease, and rare diseases

① Diseases applicable to in-hospital scenariosTesting Equipment;

② Diseases applicable to primary hospital settingsInspection and Testing Equipment / Early Screening and Diagnosis Solution Platform, to expand the accessibility of early diagnosis;

③ Innovative enterprises that can enhance the risk prediction and early screening capabilities for the aforementioned diseases through data algorithms;

Demand Two: Solutions for the respiratory field, including COPD/asthma

① Product Direction: Digital diagnostics, POCT testing equipment, digital therapeutics or auxiliary treatment devices;

②ProductMust have: Respiratory function analysis (FEV1, FVC) and the ability to determine abnormal indicators;

③ProductBest to have: Differential diagnosis in the field of respiratory diseases (such as COPD, asthma) and can provide auxiliary diagnostic suggestions;

④ProductTarget Audience: Patients with respiratory symptoms but not yet diagnosed;

Requirement Three: Public Health Medical Solutions

① Based on data and cutting-edge diagnosis and treatment technologies, it can provideEfficient Diagnosis and Treatment Solutions for Primary Healthcare Scenarios

② ForTropical DiseasesHealthcare Solutions for Different Stages of Diagnosis and Treatment

Requirement Four: A big data enterprise capable of providing services to transform in-hospital clinical information into databases and real-world research evidence.

Demand Five: API Manufacturers

Demand Six: Enterprises Related to Smoking Control Devices

2. Expected cooperation standards:

① The solution/platform can collaborate on clinical trials in Brazil through local research and ANVISA approval.

② Be able to set up an office in Brazil locally

*ANVISA is the Brazilian Health Regulatory Agency, overseeing medical devices.

3. Requirement Deadline:

January 31, 2024

4. Project cooperation direction:

● AstraZeneca Latin America Commercial Collaboration

AstraZeneca Brazil can provide local commercial cooperation partnerships, through which AstraZeneca Brazil will extend solutions to the existing Latin American ecosystem and offer financial support for some pilot/POC projects.

● Overseas Business Expansion Support (Brazil)

AstraZeneca Brazil can provide a local team (headquarters and sales force) to assist partners in expanding their market and business in Brazil.

● Empower Overseas Activities Industry Exchange

Participate in the Latin American delegation's visit to China exchange project in early 2024, where you can engage in in-depth discussions with representatives from the political, industrial, academic, research, medical, and investment sectors of the Latin American ecosystem to explore future collaboration opportunities.

Swipe up and down to view more

Project Submission Method

Step 1

Email Subject: [Saudi Arabia/Latin America Overseas, Project Name] Describe Intent, e.g., "Latin America Overseas, Digital Diagnosis Enterprise for COPD," and send BP to:iCampus@astrazeneca.com

Step Two

The project team will conduct an initial screening and reply by email within 5 working days to further understand the relevant information.

Step Three

After the project team review, a targeted invitation will be sent to the matching enterprises.

For information inquiries, please contact Yolanda Han:

iCampus@astrazeneca.com

More Directions for Collaboration

AstraZeneca Commercial Cooperation

Join the AstraZeneca ecosystem and have the opportunity to engage in commercial cooperation with AstraZeneca's business departments.

Expert Collaboration

Link with a team of experts in the field of disease treatment across China, led by academicians and experts, for technical/industry/cooperation discussions.

Fund Investment

Evaluation and对接 with the iCampus Incubation Fund, which focuses on financing projects that feature technological innovations synergistic with AstraZeneca's therapeutic areas.

Industry/Academic Activity Synergy

Invitation to participate in AstraZeneca's various ecosystem summits, industry discussions, academic roadshows, and partnership matchmaking related to the theme.

Park Entry

Priority access to入驻 nine cities (Wuxi, Beijing, Shanghai, Guangzhou, Hangzhou, Chengdu, Yixing, Qingdao, Hong Kong) International Life Science Innovation Park (iCampus) is available, offering services such as space, policy support, accelerator programs, and financing.